Genetic Signatures is a specialized molecular diagnostics company founded in 2001 by Dr. Geoffrey Grigg. The company focuses on developing and commercializing its proprietary 3base™ platform technology, which simplifies genetic sequences to enhance the detection of infectious pathogens. Under the EasyScreen™ brand, Genetic Signatures offers a suite of real-time PCR-based products that enable hospitals and pathology laboratories to rapidly and accurately screen for a wide array of infectious diseases. The company’s innovative approach has led to global expansion, with products available in over 30 countries and direct representation in the United States, United Kingdom, Germany, and Australia.